Live attenuated influenza vaccine use and safety in children and adults with asthma
Jonathan Duffy(Centers for Disease Control and Prevention), Matthew F. Daley(Kaiser Permanente), Steven J. Jacobsen(Mayo Clinic), Melissa Glenda Lewis(Centers for Disease Control and Prevention), Grace M. Lee, Edward A. Belongia(Marshfield Clinic), Theresa Harrington(Centers for Disease Control and Prevention), James D. Nordin(HealthPartners), Allison L. Naleway(Centers for Disease Control and Prevention), Roger Baxter(Unknown), Lisa A. Jackson(Kaiser Permanente Washington Health Research Institute)
Cited by 20
Related Papers
Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans
|Science|2009|2.5k
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2011|1.8k
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602